Market Pain Target chronic pain sufferers and post-injury populations with Oska Pulse as a non-drug, non-invasive alternative. Emphasize the large U.S. market for chronic pain relief and the potential to reduce dependence on medications, appealing to insurance and healthcare providers seeking cost-effective pain management options.

Clinical Validation Leverage the randomized, double-blind study backing Oska Pulse to approach clinics, physical therapy networks, sports medicine practices, and occupational health programs. Highlight evidence of inflammation reduction, mobility improvement, and minimal side effects to support formulary and product adoption discussions.

Expansion Readiness Capitalize on recent and past international push, such as India launch, to pursue partnerships in markets with growing PEMF awareness. Propose distributor arrangements, OEM opportunities, or white-label collaborations to accelerate revenue growth and geographic diversification.

Strategic Partnerships Engage healthcare associations, senior care facilities, sports teams, and employer wellness programs for group purchasing, bundles, or subsidy-enabled programs. Use the broad wellness focus to position Oska Pulse as a scalable addition to corporate wellness and rehabilitation initiatives.

Customer Retention Highlight high medication reduction among customers to build case studies with payers and health systems. Offer patient success stories, remote support, and service plans to improve long-term usage, adherence, and recurring revenue through consumables, accessories, or device upgrades.